Dihydrotestosterone is a determinant of calcaneal bone mineral density in men

Journal of Steroid Biochemistry and Molecular Biology

Volumn 117, Issue 4-5, 2009, Pages 132-138

  Ilangovan, Ramachandran ^a,b   Sittadjody, Sivanandane ^a   Balaganesh, Muthusamy ^a   Sivakumar, Ramadoss ^a   Ravi Sankar, Bhaskaran ^a   Balasubramanian, Karundevi ^a   Srinivasan, Subramanian ^c   Subramanian, Chinappa ^d   Thompson, David M ^b   Queimado, Lurdes ^b   Srinivasan, Narasimhan ^a  

^a UNIVERSITY OF MADRAS   (India)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^c Sai Orthocare Clinic   (India)

^d SRI RAMACHANDRA UNIVERSITY   (India)

Author keywords

Androgens; BMD; Cytokines; DHT; IGFBPs; IGFs

Indexed keywords

ANDROSTANOLONE; ESTRADIOL; GAMMA INTERFERON; INTERLEUKIN 1BETA; INTERLEUKIN 4; PARATHYROID HORMONE; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; TESTOSTERONE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGE; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE TURNOVER; CALCANEUS; CONTROLLED STUDY; CYTOKINE RELEASE; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPOROSIS; PROTEIN BLOOD LEVEL; STEROID BLOOD LEVEL;

ABSORPTIOMETRY, PHOTON; ADULT; AGED; BODY MASS INDEX; BONE DENSITY; CALCANEUS; CASE-CONTROL STUDIES; DIHYDROTESTOSTERONE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS;

EID: 70350329299     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2009.08.004     Document Type: Article

References (54)

1. Riggs B.L., Khosla S., and Melton III L.J. Sex steroids and the construction and conservation of the adult skeleton. Endocr. Rev. 23 3 (2002) 279-302
2. Saad F., and Gooren L. The role of testosterone in the metabolic syndrome: a review. J. Steroid Biochem. Mol. Biol. 114 1-2 (2009) 40-43
3. Vandenput L., Ederveen A.G., Erben R.G., Stahr K., Swinnen J.V., Van Herck E., Verstuyf A., Boonen S., Bouillon R., and Vanderschueren D. Testosterone prevents orchidectomy-induced bone loss in estrogen receptor-alpha knockout mice. Biochem. Biophys. Res. Commun. 285 1 (2001) 70-76
4. Szulc P., Munoz F., Claustrat B., Garnero P., Marchand F., Duboeuf F., and Delmas P.D. Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study. J. Clin. Endocrinol. Metab. 86 1 (2001) 192-199
5. Gennari L., Merlotti D., Martini G., Gonnelli S., Franci B., Campagna S., Lucani B., Dal Canto N., Valenti R., Gennari C., and Nuti R. Longitudinal association between sex hormone levels, bone loss, and bone turnover in elderly men. J. Clin. Endocrinol. Metab. 88 11 (2003) 5327-5333
6. Goltzman D. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone. Arch. Biochem. Biophys. 473 2 (2008) 218-224
7. Roodman G.D. Role of cytokines in the regulation of bone resorption. Calcif. Tissue Int. 53 Suppl. 1 (1993) S94-S98
8. Compston J.E. Sex steroids and bone. Physiol. Rev. 81 1 (2001) 419-447
9. Jehle P.M., Schulten K., Schulz W., Jehle D.R., Stracke S., Manfras B., Boehm B.O., Baylink D.J., and Mohan S. Serum levels of insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-1 to -6 and their relationship to bone metabolism in osteoporosis patients. Eur. J. Intern. Med. 14 1 (2003) 32-38
10. Syed F., and Khosla S. Mechanisms of sex steroid effects on bone. Biochem. Biophys. Res. Commun. 328 3 (2005) 688-696
11. Leslie W.D., Adler R.A., El-Hajj Fuleihan G., Hodsman A.B., Kendler D.L., McClung M., Miller P.D., and Watts N.B. Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: the 2005 ISCD Official Positions. J. Clin. Densitom. 9 1 (2006) 22-30
12. Sufi S.B., Donaldson A., and Jeffcoate S.L. Testosterone Assay: World Health Organization Collaborating Center for Research and Reference Services in the Immunoassay of Hormones in Human Reproduction. 10th edition (1986) pp. 57-69
13. Andersch M.A., and Szecypinski A.J. Use of p-nitrophenyl phosphate as the substrate for determination of serum acid phosphatase. Am. J. Clin. Pathol. 17 (1947) 571-574
14. Tenniswood M., Bird C.E., and Clark A.F. Acid phosphatases: androgen dependent markers of rat prostate. Can. J. Biochem. 54 4 (1976) 350-357
15. Thompson P.W., Taylor J., Oliver R., and Fisher A. Quantitative ultrasound (QUS) of the heel predicts wrist and osteoporosis-related fractures in women age 45-75 years. J. Clin. Densitom. 1 3 (1998) 219-225
16. Miller P.D., Siris E.S., Barrett-Connor E., Faulkner K.G., Wehren L.E., Abbott T.A., Chen Y.T., Berger M.L., Santora A.C., and Sherwood L.M. Prediction of fracture risk in postmenopausal white women with peripheral bone densitometry: evidence from the National Osteoporosis Risk Assessment. J. Bone Miner. Res. 17 12 (2002) 2222-2230
17. Amory J.K., Watts N.B., Easley K.A., Sutton P.R., Anawalt B.D., Matsumoto A.M., Bremner W.J., and Tenover J.L. Exogenous testosterone or testosterone with finasteride increases bone mineral density in older men with low serum testosterone. J. Clin. Endocrinol. Metab. 89 2 (2004) 503-510
18. Li J., and Kim J. Molecular profiles of finasteride effects on prostate carcinogenesis. Cancer Prev. Res. (Phila Pa) 2 6 (2009) 518-524
19. Issa S., Schnabel D., Feix M., Wolf L., Schaefer H.E., Russell D.W., and Schweikert H.U. Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1. J. Clin. Endocrinol. Metab. 87 12 (2002) 5401-5407
20. Hanada K., Furuya K., Yamamoto N., Nejishima H., Ichikawa K., Nakamura T., Miyakawa M., Amano S., Sumita Y., and Oguro N. Bone anabolic effects of S-40503, a novel nonsteroidal selective androgen receptor modulator (SARM), in rat models of osteoporosis. Biol. Pharm. Bull. 26 11 (2003) 1563-1569
21. Anderson R.A., Wallace A.M., Sattar N., Kumar N., and Sundaram K. Evidence for tissue selectivity of the synthetic androgen 7 alpha-methyl-19-nortestosterone in hypogonadal men. J. Clin. Endocrinol. Metab. 88 6 (2003) 2784-2793
22. LaMorte A., Kumar N., Bardin C.W., and Sundaram K. Aromatization of 7 alpha-methyl-19-nortestosterone by human placental microsomes in vitro. J. Steroid Biochem. Mol. Biol. 48 2-3 (1994) 297-304
23. Dequeker J., and Geusens P. Anabolic steroids and osteoporosis. Acta Endocrinol. Suppl. (Copenh.) 271 (1985) 45-52
24. Behre H.M., Kliesch S., Leifke E., Link T.M., and Nieschlag E. Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J. Clin. Endocrinol. Metab. 82 8 (1997) 2386-2390
25. Daniell H.W., Dunn S.R., Ferguson D.W., Lomas G., Niazi Z., and Stratte P.T. Progressive osteoporosis during androgen deprivation therapy for prostate cancer. J. Urol. 163 1 (2000) 181-186
26. Vanderschueren D., Vandenput L., Boonen S., Van Herck E., Swinnen J.V., and Bouillon R. An aged rat model of partial androgen deficiency: prevention of both loss of bone and lean body mass by low-dose androgen replacement. Endocrinology 141 5 (2000) 1642-1647
27. Basurto L., Zarate A., Gomez R., Vargas C., Saucedo R., and Galvan R. Effect of testosterone therapy on lumbar spine and hip mineral density in elderly men. Aging Male 11 3 (2008) 140-145
28. Hofbauer L.C., and Khosla S. Androgen effects on bone metabolism: recent progress and controversies. Eur. J. Endocrinol. 140 4 (1999) 271-286
29. Mellstrom D., Johnell O., Ljunggren O., Eriksson A.L., Lorentzon M., Mallmin H., Holmberg A., Redlund-Johnell I., Orwoll E., and Ohlsson C. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. J. Bone Miner. Res. 21 4 (2006) 529-535
30. McPhaul M.J., and Young M. Complexities of androgen action. J. Am. Acad. Dermatol. 45 3 Suppl. (2001) S87-S94
31. Compston J.E. Bone marrow and bone: a functional unit. J. Endocrinol. 173 3 (2002) 387-394
32. Vanderschueren D., Van Herck E., Suiker A.M., Visser W.J., Schot L.P., Chung K., Lucas R.S., Einhorn T.A., and Bouillon R. Bone and mineral metabolism in the androgen-resistant (testicular feminized) male rat. J. Bone Miner. Res. 8 7 (1993) 801-809
33. Turner R.T., Wakley G.K., and Hannon K.S. Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats. J. Orthop. Res. 8 4 (1990) 612-617
34. Center J.R., Nguyen T.V., Sambrook P.N., and Eisman J.A. Hormonal and biochemical parameters and osteoporotic fractures in elderly men. J. Bone Miner. Res. 15 7 (2000) 1405-1411
35. Legrand E., Hedde C., Gallois Y., Degasne I., Boux de Casson F., Mathieu E., Basle M.F., Chappard D., and Audran M. Osteoporosis in men: a potential role for the sex hormone binding globulin. Bone 29 1 (2001) 90-95
36. Slemenda C.W., Longcope C., Zhou L., Hui S.L., Peacock M., and Johnston C.C. Sex steroids and bone mass in older men. Positive associations with serum estrogens and negative associations with androgens. J. Clin. Invest. 100 7 (1997) 1755-1759
37. Center J.R., Nguyen T.V., Sambrook P.N., and Eisman J.A. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J. Clin. Endocrinol. Metab. 84 10 (1999) 3626-3635
38. Amin S., Zhang Y., Felson D.T., Sawin C.T., Hannan M.T., Wilson P.W., and Kiel D.P. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. Am. J. Med. 119 5 (2006) 426-433
39. Fink H.A., Ewing S.K., Ensrud K.E., Barrett-Connor E., Taylor B.C., Cauley J.A., and Orwoll E.S. Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men. J. Clin. Endocrinol. Metab. 91 10 (2006) 3908-3915
40. Boonen S., Mohan S., Dequeker J., Aerssens J., Vanderschueren D., Verbeke G., Broos P., Bouillon R., and Baylink D.J. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis. J. Bone Miner. Res. 14 12 (1999) 2150-2158
41. Guler H.P., Zapf J., Scheiwiller E., and Froesch E.R. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc. Natl. Acad. Sci. U.S.A. 85 13 (1988) 4889-4893
42. Ghiron L.J., Thompson J.L., Holloway L., Hintz R.L., Butterfield G.E., Hoffman A.R., and Marcus R. Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women. J. Bone Miner. Res. 10 12 (1995) 1844-1852
43. Mohan S., Farley J.R., and Baylink D.J. Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: implications for bone loss with aging. Prog. Growth Factor Res. 6 2-4 (1995) 465-473
44. Janssen J.A., Uitterlinden P., Hofland L.J., and Lamberts S.W. Insulin-like growth factor I receptors on blood cells: their relationship to circulating total and "free" IGF-I, IGFBP-1, IGFBP-3 and insulin levels in healthy subjects. Growth Horm. IGF Res. 8 1 (1998) 47-54
45. Kurland E.S., Chan F.K., Rosen C.J., and Bilezikian J.P. Normal growth hormone secretory reserve in men with idiopathic osteoporosis and reduced circulating levels of insulin-like growth factor-I. J. Clin. Endocrinol. Metab. 83 7 (1998) 2576-2579
46. Gori F., Hofbauer L.C., Conover C.A., and Khosla S. Effects of androgens on the insulin-like growth factor system in an androgen-responsive human osteoblastic cell line. Endocrinology 140 12 (1999) 5579-5586
47. Kasperk C., Fitzsimmons R., Strong D., Mohan S., Jennings J., Wergedal J., and Baylink D. Studies of the mechanism by which androgens enhance mitogenesis and differentiation in bone cells. J. Clin. Endocrinol. Metab. 71 5 (1990) 1322-1329
48. Canalis E. Interleukin-1 has independent effects on deoxyribonucleic acid and collagen synthesis in cultures of rat calvariae. Endocrinology 118 1 (1986) 74-81
49. Tashjian Jr. A.H., Voelkel E.F., Lazzaro M., Goad D., Bosma T., and Levine L. Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. Endocrinology 120 5 (1987) 2029-2036
50. Harada S., and Rodan G.A. Control of osteoblast function and regulation of bone mass. Nature 423 6937 (2003) 349-355
51. Khalkhali-Ellis Z., Handa R.J., Price Jr. R.H., Adams B.D., Callaghan J.J., and Hendrix M.J. Androgen receptors in human synoviocytes and androgen regulation of interleukin 1beta (IL-1beta) induced IL-6 production: a link between hypoandrogenicity and rheumatoid arthritis?. J. Rheumatol. 29 9 (2002) 1843-1846
52. Pilbeam C.C., and Raisz L.G. Effects of androgens on parathyroid hormone and interleukin-1-stimulated prostaglandin production in cultured neonatal mouse calvariae. J. Bone Miner. Res. 5 11 (1990) 1183-1188
53. Takei S., Redford A., Katayama S., and Toyoda H. Destabilization of tumor necrosis factor-alpha mRNA by 5-alpha dihydrotestosterone in Jurkat cells. Life. Sci. 66 20 (2000) PL277-282
54. Lacey D.L., Erdmann J.M., Teitelbaum S.L., Tan H.L., Ohara J., and Shioi A. Interleukin 4, interferon-gamma, and prostaglandin E impact the osteoclastic cell-forming potential of murine bone marrow macrophages. Endocrinology 136 6 (1995) 2367-2376